ArticleUrology case reports2026
Incidental intraprostatic paraganglioma: Case report and review of the literature.
Article in Urology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intraprostatic paraganglioma (PGL) is a rare neuroendocrine tumor arising from chromaffin cells and poses diagnostic and management challenges. We report a 63-year-old man with Grade Group 3 prostate adenocarcinoma who underwent robotic radical prostatectomy and was incidentally found to have a 1.5 mm intraprostatic PGL on final pathology. The patient had no catecholamine-related symptoms, and postoperative plasma metanephrines were normal, consistent with a nonfunctional tumor. Immunohistochemical staining supported the diagnosis. The patient elected surveillance and remains asymptomatic. This case highlights the variable presentation of prostatic PGL and emphasizes the role of pathologic evaluation, biochemical testing, and individualized management strategies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.